Michele Trezzi

709 total citations
11 papers, 172 citations indexed

About

Michele Trezzi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Michele Trezzi has authored 11 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Michele Trezzi's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (4 papers). Michele Trezzi is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (4 papers). Michele Trezzi collaborates with scholars based in Italy, United Kingdom and United States. Michele Trezzi's co-authors include Angela Bechini, Maurizio Zazzi, Paola Corsi, Marta Luisa Ciofi degli Atti, Filippo Ansaldi, Andrea De Luca, Denise Tavares Giannini, Simona Di Giambenedetto, L. Incandela and Paolo Bonanni and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Medicine and European Journal of Clinical Investigation.

In The Last Decade

Michele Trezzi

11 papers receiving 167 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Trezzi Italy 6 108 58 47 32 28 11 172
Peter O. Okokhere Nigeria 9 181 1.7× 91 1.6× 7 0.1× 9 0.3× 32 1.1× 22 262
Nicole Engen United States 9 175 1.6× 105 1.8× 55 1.2× 25 0.8× 27 1.0× 18 275
Elena Álvarez Spain 7 144 1.3× 66 1.1× 76 1.6× 13 0.4× 10 0.4× 12 239
Gabriele Pagani Italy 8 92 0.9× 29 0.5× 10 0.2× 20 0.6× 13 0.5× 21 163
Salma AlBahrani Saudi Arabia 9 153 1.4× 72 1.2× 14 0.3× 53 1.7× 6 0.2× 28 265
Davide Minisci Italy 9 257 2.4× 71 1.2× 39 0.8× 55 1.7× 10 0.4× 18 326
Sirintip Sricharoenchai Thailand 8 70 0.6× 84 1.4× 32 0.7× 7 0.2× 12 0.4× 14 183
Gloria Sampériz Spain 6 76 0.7× 118 2.0× 17 0.4× 7 0.2× 14 0.5× 14 162
Agata Skrzat‐Klapaczyńska Poland 7 73 0.7× 47 0.8× 9 0.2× 12 0.4× 7 0.3× 24 112
Agathe Rami France 9 80 0.7× 72 1.2× 75 1.6× 2 0.1× 8 0.3× 10 175

Countries citing papers authored by Michele Trezzi

Since Specialization
Citations

This map shows the geographic impact of Michele Trezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Trezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Trezzi more than expected).

Fields of papers citing papers by Michele Trezzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Trezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Trezzi. The network helps show where Michele Trezzi may publish in the future.

Co-authorship network of co-authors of Michele Trezzi

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Trezzi. A scholar is included among the top collaborators of Michele Trezzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Trezzi. Michele Trezzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Trezzi, Michele, Emanuele Focà, Paola Cinque, et al.. (2022). Long-acting drugs: people’s expectations and physicians’ preparedness. Are we readying to manage it? An Italian survey. Medicine. 101(42). e30052–e30052. 4 indexed citations
2.
Morici, Nuccia, Gian Marco Podda, Simone Birocchi, et al.. (2021). Enoxaparin for thromboprophylaxis in hospitalized COVID‐19 patients: The X‐COVID‐19 Randomized Trial. European Journal of Clinical Investigation. 52(5). e13735–e13735. 31 indexed citations
3.
Orsucci, Daniele, Michele Trezzi, Roberto Anichini, et al.. (2021). Increased Creatine Kinase May Predict A Worse COVID-19 Outcome. Journal of Clinical Medicine. 10(8). 1734–1734. 32 indexed citations
4.
Trezzi, Michele, et al.. (2016). Streptococcus agalactiae: prevalence of antimicrobial resistance in vaginal and rectal swabs in Italian pregnant women.. PubMed. 24(3). 217–21. 27 indexed citations
5.
Manzi, Fatuma, et al.. (2015). Prevalence of Tuberculosis infection among teen-agers in Tuscany. PubMed. 47(4). 151–4. 1 indexed citations
6.
Cenderello, Giovanni, Benedetto Maurizio Celesia, Michele Trezzi, et al.. (2014). Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort. ClinicoEconomics and Outcomes Research. 7. 27–27. 5 indexed citations
8.
Bracciale, Laura, Manuela Colafigli, Maurizio Zazzi, et al.. (2009). Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors. Journal of Antimicrobial Chemotherapy. 64(3). 607–615. 27 indexed citations
9.
Giambenedetto, Simona Di, Maurizio Zazzi, Paola Corsi, et al.. (2008). Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. Antiviral Therapy. 14(3). 359–369. 12 indexed citations
10.
Zazzi, Maurizio, Paola Corsi, Massimo Di Pietro, et al.. (2006). Evolution of the prevalence of HIV drug resistance patterns over 9 years of HAART and its relation with changes in the failing treatment regimens: an analysis of a large Italian database. 3 indexed citations
11.
Incandela, L., Angela Bechini, Denise Tavares Giannini, et al.. (2006). Measles outbreak in Grosseto, central Italy, 2006. Weekly releases (1997–2007). 11(31). E060803.4–E060803.4. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026